Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model. [electronic resource]
Producer: 20160418Description: 103-10 p. digitalISSN:- 1534-6080
- Administration, Oral
- Allografts
- Animals
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Chronic Disease
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Graft Rejection -- enzymology
- Indoles -- administration & dosage
- Kidney -- drug effects
- Kidney Transplantation -- adverse effects
- Male
- Muscle, Smooth, Vascular -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Neointima
- Platelet-Derived Growth Factor -- antagonists & inhibitors
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-sis -- antagonists & inhibitors
- Pyrroles -- administration & dosage
- Rats, Wistar
- Signal Transduction -- drug effects
- Sunitinib
- Time Factors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor B -- antagonists & inhibitors
- Vascular Endothelial Growth Factors -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.